Worldwide Clinical Trials Expands Executive Team with Key New Hire, Mike Mencer as EVP and General Manager, Early Phase Services
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Business Wire
MORRISVILLE, N.C.--(BUSINESS WIRE)--Worldwide Clinical Trials, Inc. (Worldwide), an award-winning, full-service, midsize, global contract research organization (CRO), announced today that Mike Mencer has joined the company as the EVP and General Manager of Worldwide’s Early Phase Services, focusing on the Bioanalysis Lab in Austin, Texas, and the Clinical Pharmacology Unit (CPU) clinic in San Antonio, Texas.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200219005180/en/Mike Mencer, EVP and General Manager, Worldwide Clinical Trials (Photo: Business Wire)According to the Pharma Intelligence Pharma R&D Annual Review 2019, the number of drugs in Phase I has increased by 7.2%. Mencer brings 28 years of experience in the pharmaceutical industry to the award-winning Worldwide Phase I team, which is known for easing the burden of budget pressures, tight timelines and the changing regulatory environment for Top 100 biopharma co
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Cell Therapy Technologies market is projected to grow at a CAGR of 10.7% by 2034: Visiongain [Yahoo! Finance]Yahoo! Finance
- Global Cell Expansion Market Landscape 2024-2029 Featuring Analysis of Thermo Fisher Scientific, Danaher Corp, Merck, Sartorius, Corning, and More [Yahoo! Finance]Yahoo! Finance
- Global Metabolism Assays Market Forecast to Reach $2.5 Billion by 2030: Focus on Spectrometry Technology and Diagnostic Applications [Yahoo! Finance]Yahoo! Finance
- TMO vs. IDXX: Which Stock Is the Better Value Option? [Yahoo! Finance]Yahoo! Finance
- Global Biochips Market Size and Share to Grow by 2030, Accesses DelveInsight | Key Players in the Market - Thermo Fisher Scientific, Agilent Technologies, GE Healthcare, Qiagen, Abbott, Hoffmann La-Roche, Cepheid [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 1/31/24 - Beat
TMO
Sec Filings
- 4/9/24 - Form ARS
- 4/9/24 - Form DEFA14A
- 4/9/24 - Form DEF
- TMO's page on the SEC website